Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-03-30FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA granted supplemental approval for a generic venlafaxine hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2023-03-24FDA Approved: FETZIMA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Fetzima (levomilnacipran hydrochloride) from Allergan, Inc., representing a regulatory action re…
-
FDA approval · 2023-03-23FDA Approved: PAROXETINE — Supplemental Application (Modavar Pharmaceuticals LLC)
FDA approved a supplemental application for generic paroxetine filed by Modavar Pharmaceuticals LLC under ANDA212645.
-
FDA approval · 2023-03-22FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for trazodone hydrochloride from Apotex Corp, indicating approval of a generic product under an ANDA…
-
FDA approval · 2023-03-20FDA Approved: CLOMIPRAMINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original abbreviated new drug application for clomipramine hydrochloride (generic) by Aurobindo Pharma Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-03-15FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for escitalopram oxalate submitted by Exelan Pharmaceuticals Inc.
-
FDA approval · 2023-02-17FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic doxepin hydrochloride for oral use under an Original Application (ANDA).
-
FDA approval · 2023-02-16FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for escitalopram oxalate from Amneal Pharmaceuticals LLC, confirming approval of their generic produ…
-
FDA approval · 2023-02-08FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (CIPLA USA INC.,)
FDA approved a supplemental application for Bupropion hydrochloride submitted by Cipla USA Inc., reflecting a regulatory action on an existi…
-
FDA approval · 2023-02-07FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Cadila Pharmaceuticals Limited)
FDA approved a supplemental application for bupropion hydrochloride submitted by Cadila Pharmaceuticals Limited.
-
FDA approval · 2023-02-07FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Bupropion hydrochloride from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals Inc.), rep…
-
FDA approval · 2023-02-03FDA Approved: BREXPIPRAZOLE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original application for brexpiprazole (brexpiprazole), authorizing a generic version of the antipsych…
-
FDA approval · 2023-01-31FDA Approved: ARIPIPRAZOLE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for aripiprazole filed by VistaPharm, LLC, marking approval of a supplemental submission for this ge…
-
FDA approval · 2023-01-31FDA Approved: PAROXETINE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for paroxetine from ANI Pharmaceuticals, indicating an approved change to the product (e.g., lab…
-
FDA approval · 2023-01-25FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
The FDA approved a supplemental application for Zoloft (sertraline hydrochloride) filed by Roerig.
-
FDA approval · 2023-01-23FDA Approved: DESVENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for desvenlafaxine succinate from Alembic Pharmaceuticals Limited, enabling the marketing of a gener…
-
FDA approval · 2023-01-18FDA Approved: MIRTAZAPINE — Original Application (Prasco Laboratories)
FDA approved Prasco Laboratories' Original Application for a generic mirtazapine product. Mirtazapine is indicated for the treatment of majo…
-
FDA approval · 2023-01-09FDA Approved: BUPROPION HYDROCHLORIDE SR — Original Application (Epic Pharma, LLC)
FDA approved Epic Pharma's generic bupropion hydrochloride sustained-release (BHCl SR) under an Original Application.
-
FDA approval · 2022-12-13FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Bupropion submitted by Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2022-12-06FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Wellbutrin SR (bupropion hydrochloride) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2022-12-06FDA Approved: VILAZODONE HYDROCHLORIDE — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved Exelan Pharmaceuticals' original application for vilazodone hydrochloride, providing a generic version of vilazodone hydrochlor…
-
FDA approval · 2022-12-05FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA has approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride, allowing the generic to be marketed as part o…
-
FDA approval · 2022-11-29FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for escitalopram oxalate (a generic version of Lexapro), enabling market entry…
-
FDA approval · 2022-11-29FDA Approved: ESCITALOPRAM — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for escitalopram from Macleods Pharmaceuticals Limited, enabling the marketing of their generic …
-
FDA approval · 2022-11-28FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approves the original application for venlafaxine hydrochloride tablets from Rising Pharma Holdings, Inc., making a generic version …